Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Wednesday, November 9, 2022, 7:12
- PR Newswire
- Add a comment
HAMILTON, ON and BOSTON, Nov. 9, 2022 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the compensation committee of the Company’s Board of…
About the Author
admin has written 20655 stories on this site.